June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Parthanatos: A new way of retinal cell death in endophthalmitis
Author Affiliations & Notes
  • Zeeshan Ahmad
    Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Sukhvinder Singh
    Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Ashok Kumar
    Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Zeeshan Ahmad None; Sukhvinder Singh None; Ashok Kumar None
  • Footnotes
    Support  NIH grant R01EY026964, R01EY027381, and R21AI140033
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3792. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zeeshan Ahmad, Sukhvinder Singh, Ashok Kumar; Parthanatos: A new way of retinal cell death in endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3792.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Our untargeted metabolomics analysis revealed a time-dependent reduction in retinal NAD+ levels with a concomitant increase in necrotic cell death during experimental bacterial (S. aureus) endophthalmitis. We hypothesized that high levels of poly (ADP-ribose) polymerase 1 (PARP1) activity cause rapid NAD+ depletion and triggers parthanatos cell death pathway during endophthalmitis. The aim of this study is to investigate the role of parthanatos in the pathobiology of bacterial endophthalmitis and decipher underlying mechanisms.

Methods : In vivo (C57BL/6 mouse) and in vitro (BMDMs, retinal Muller glia) studies were performed using pharmacological inhibitors of PARP1 and calpain signaling pathways. In mice, disease progression was assessed by non-invasive (ERG and fundus exam) and invasive (bacterial burden, cytokine levels) methods. PARP1 activity was measured by fluorescent NAD+ substrate (6-Fluo-10-NAD+) on unfixed bacterial infected retinal tissue. Similarly, calpain substrate t-BOC-Leu-Met-CMAC (CMAC) was used to assess the calpain activity. Live cell imaging was performed to determine the effect of inhibitors on cell viability. The expression of protein levels was detected by western blot and immunofluorescence whereas transcript levels were checked with qPCR. The expression of inflammatory mediators in retinal tissue or cell lysates were estimated with ELISA.

Results : S. aureus infection induced the expression of PARP1 and Calpain in mouse retina. This coincided with increased PARP1 and Calpain activity in infected tissues. Both PARP1 or calpain inhibitors reduced parthanatos signaling resulting in diminished retinal inflammation and reduced retinal cell death. Calpain inhibitor reduced calcium buildup in infected mouse retinas and Muller glia. Our data showed that reducing PARP1 and Calpain overactivation restored cellular NAD+ and ATP levels. Moreover, NLRP3 inflammasome activation and IL-1β production is reduced by PARP1 and Calpain inhibitors in both in vivo and in vitro.

Conclusions : Our study demonstrates the activation of parthanatos in bacterial endophthalmitis and emphasizes the role of NAD+ metabolism in regulating inflammatory cell death. Moreover, the inhibition of calpain activity could be a promising therapeutic target in ameliorating endophthalmitis.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×